HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The protective effects of dexmedetomidine on hepatic ischemia reperfusion injury.

AbstractOBJECTIVE:
The aim of this study was to evaluate the effect of dexmedetomidine (100 µg/kg-ip) on liver ischemia and reperfusion (I/R) in rats.
METHODS:
Twenty-four Wistar Albino rats were separated into three groups as control (C), ischemia-reperfusion injury (I/R) and dexmedetomidine group (I/R-D). Ischemia was induced with portal clampage for 45 minutes and reperfusion period was 45 minutes after declampage. Group I/R-D was received dexmedetomidine 100 µg/kg i.p. 30 min before portal clampage. Thiobarbutiric Acid-Reactive Substances (TBARS), glutathioneS-transferase (GST), superoxide dismutase (SOD), Catalase (CAT), and Paraoxonase 1 (PON-1) were investigated in blood samples. Also HSP60 and p53-positive hepatocytes were counted under ImageJ image analysis program.
RESULTS:
All parameters, except GST levels, were significant between the groups (p < 0.05). Although HSP60 expression was significantly increased between I/R, I/R-D and C groups there were no significant differences between I/R-D and C (p = 0.443). On the other hand, p53 expression was also significantly increased between I/R, I/R-D and C groups At the same time, there were no significant differences between I/R-D and C groups (p = 0.354).
CONCLUSION:
All the results suggest that dexmedetomidine has beneficial effects on liver ischemia/reperfusion stress (Tab. 1, Fig. 2, Ref. 49).
AuthorsA Kucuk, F Yaylak, A Cavunt-Bayraktar, M Tosun, M Arslan, F M Comu, M Kavutcu
JournalBratislavske lekarske listy (Bratisl Lek Listy) Vol. 115 Issue 11 Pg. 680-4 ( 2014) ISSN: 0006-9248 [Print] Slovakia
PMID25428535 (Publication Type: Journal Article)
Chemical References
  • Protective Agents
  • Dexmedetomidine
Topics
  • Animals
  • Dexmedetomidine (pharmacology)
  • Ischemia (drug therapy)
  • Ischemic Preconditioning (methods)
  • Liver (blood supply)
  • Liver Diseases (drug therapy, prevention & control)
  • Protective Agents (pharmacology)
  • Random Allocation
  • Rats
  • Rats, Wistar
  • Reperfusion Injury (drug therapy, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: